TGF-β enhances production and inhibits degradation of extracellular matrix and has been reported to be upregulated in human and experimental diabetic kidney disease, suggesting TGF-β is a key driver of this process in DN [35]. The gene discussed is TGFB1; the disease is diabetic kidney disease.